BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Post-Approval (Research/Post Marketing/Phase IV)
Positive Trial Results for Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO)'s Abilify Maintena in Schizophrenia 5/22/2013 6:56:52 AM    More...
"Love Hormone" Promises Safer Births After Pfizer Inc. (PFE) Flop 5/20/2013 7:37:11 AM    More...
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO): Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1 5/21/2013 10:55:14 AM    More...
Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients With Schizophrenia Compared to Seroquel XR® (quetiapine XR) 5/21/2013 10:51:38 AM    More...
Sunovion Pharmaceuticals Inc. Presents Results From a One-year, Large Simple Safety Study of BROVANA® (arformoterol tartrate) Inhalation Solution 5/20/2013 10:23:33 AM    More...
Bristol-Myers Squibb Company (BMY) Drug Cocktail Stymies Melanoma Tumors 5/16/2013 7:32:59 AM    More...
UCB, Inc. (UCBJF.PK) Release: New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome 5/17/2013 9:23:36 AM    More...
Why Does Arena Pharmaceuticals, Inc. (ARNA)'s Obesity Drug Have Abuse Potential? 5/13/2013 7:15:26 AM    More...
US WorldMeds, LLC Release: New Clinical Trial Investigates APOKYN for Treating Debilitating Morning Akinesia in Parkinson’s Disease Patients 5/13/2013 9:58:07 AM    More...
Sex Supplements Often Contain Viagra Ingredients, Pfizer Inc. (PFE) Reveals 5/10/2013 8:06:51 AM    More...
Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin® (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma 5/9/2013 11:37:13 AM    More...
Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) Announce Publication of ARISTOTLE Subanalysis in Circulation 5/7/2013 11:16:09 AM    More...
AlphaMed Release: Study Shows Dual Targeting of HER2 and HR-Positive Metastatic Breast Cancer Improves Survival Rates 5/7/2013 9:27:58 AM    More...
European Medicines Agency Ordered Not to Release AbbVie (ABBV)'s Trial Data, for Now 5/1/2013 8:08:27 AM    More...
Pfizer Inc. (PFE)'s Celebrex Meets Goals in Juvenile Rheumatoid Arthritis Study 4/25/2013 7:03:59 AM    More...
1234567